Role of MicroRNA-30c in cancer progression

被引:38
作者
Han, Wenyan [1 ]
Cui, Hongwei [2 ]
Liang, Junqing [3 ]
Su, Xiulan [2 ]
机构
[1] Inner Mongolia Med Univ, Lab Affiliated Hosp 2, 1 Yingfang Rd, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Affiliated Hosp, Clin Med Res Ctr, Inner Mongolia Key Lab Med Cellular Biol, Hohhot 010050, Inner Mongolia, Peoples R China
[3] Inner Mongolia Autonomous Reg Canc Hosp, Dept Breast Oncol, Hohhot 010050, Inner Mongolia, Peoples R China
来源
JOURNAL OF CANCER | 2020年 / 11卷 / 09期
基金
中国国家自然科学基金;
关键词
microRNAs; microRNA-30c; cancer progression; cancer treatment; cancer prognosis; TUMOR-SUPPRESSOR; LUNG-CANCER; RNA-INTERFERENCE; EXPRESSION; MIR-30C; GENES; POLYMORPHISMS; CARCINOMA; CELLS; CONTRIBUTES;
D O I
10.7150/jca.38449
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs or miRs) is a non-coding small RNA of a type of 18 similar to 24 nucleotide-regulated gene that has been discovered in recent years. It mainly degrades the target gene mRNA or inhibits its translation process through the complete or incomplete bindings with 3'UTR of target genes, followed by the regulation of individual development, apoptosis, proliferation, differentiation and other life activities through the post-transcriptional regulation. Among many miRNAs, the microRNA family, miR-30, plays diverse roles in these key process of neoplastic transformation, metastasis, and clinical outcomes in different cancer progression. As key member of miR-30, miR-30c is regulated by oncogenic transcription factors and cancer progression related genes. Recently, numerous studies have demonstrated that the aberrant expression of miR-30c was significantly associated with the majority of human cancer progression. In this review, the diverse roles of miR-30c in different cancer progression such as the cellular and molecular mechanisms, the potential applications in clinics were summarized to speculate the benefits of miR-30c over-expression in cancer treatment and prognosis.
引用
收藏
页码:2593 / 2601
页数:9
相关论文
共 63 条
  • [1] Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides
    Benner, Marchina F.
    Ballabio, Erica
    van Kester, Marloes S.
    Saunders, Nigel J.
    Vermeer, Maarten H.
    Willemze, Rein
    Lawrie, Charles H.
    Tensen, Cornelis P.
    [J]. EXPERIMENTAL DERMATOLOGY, 2012, 21 (08) : 632 - 634
  • [2] Role for a bidentate ribonuclease in the initiation step of RNA interference
    Bernstein, E
    Caudy, AA
    Hammond, SM
    Hannon, GJ
    [J]. NATURE, 2001, 409 (6818) : 363 - 366
  • [3] MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
    Bockhorn, Jessica
    Yee, Kathy
    Chang, Ya-Fang
    Prat, Aleix
    Huo, Dezheng
    Nwachukwu, Chika
    Dalton, Rachel
    Huang, Simo
    Swanson, Kaitlin E.
    Perou, Charles M.
    Olopade, Olufunmilayo I.
    Clarke, Michael F.
    Greene, Geoffrey L.
    Liu, Huiping
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 373 - 382
  • [4] Principles of MicroRNA-target recognition
    Brennecke, J
    Stark, A
    Russell, RB
    Cohen, SM
    [J]. PLOS BIOLOGY, 2005, 3 (03): : 404 - 418
  • [5] MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications
    Busacca, Sara
    Germano, Serena
    De Cecco, Loris
    Rinaldi, Maurizio
    Comoglio, Federico
    Faverot, Francesco
    Murer, Bruno
    Mutti, Luciano
    Pierotti, Marco
    Gaudino, Giovanni
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2010, 42 (03) : 312 - 319
  • [6] Widespread microRNA repression by Myc contributes to tumorigenesis
    Chang, Tsung-Cheng
    Yu, Duonan
    Lee, Yun-Sil
    Wentzel, Erik A.
    Arking, Dan E.
    West, Kristin M.
    Dang, Chi V.
    Thomas-Tikhonenko, Andrei
    Mendell, Joshua T.
    [J]. NATURE GENETICS, 2008, 40 (01) : 43 - 50
  • [7] MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation
    Cheerla, Nikhil
    Gevaert, Olivier
    [J]. BMC BIOINFORMATICS, 2017, 18
  • [8] miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
    Croset, Martine
    Pantano, Francesco
    Kan, Casina W. S.
    Bonnelye, Edith
    Descotes, Francoise
    Alix-Panabieres, Catherine
    Lecellier, Charles-Henri
    Bachelier, Richard
    Allioli, Nathalie
    Hong, Saw-See
    Bartkowiak, Kai
    Pantel, Klaus
    Clezardin, Philippe
    [J]. CANCER RESEARCH, 2018, 78 (18) : 5259 - 5273
  • [9] The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
    Egeland, Nina G.
    Lunde, Siri
    Jonsdottir, Kristin
    Lende, Tone H.
    Cronin-Fenton, Deirdre
    Gilje, Bjornar
    Janssen, Emiel A. M.
    Soiland, Havard
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10) : 24243 - 24275
  • [10] Fan MJ, 2017, EUR REV MED PHARMACO, V21, P2642